Stay updated on Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.

Latest updates to the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.4 to the page's revision history and removed Revision: v3.3.3. This is a minor metadata update that does not affect the study content or user-facing information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Locations section was updated with new sites across multiple US states and international locations (including Deutschland, Hesse, Greater London, Greater Manchester, HAMPSHIRE). Several previously listed sites were removed, aligning with revision v3.3.3 (previously v3.3.2).SummaryDifference2%

- Check55 days agoChange DetectedPage footer revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoval of the government funding/status notice is not expected to affect the study details presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedAdded a new study site entry for Southampton, Hampshire, United Kingdom (SO16 6DU) on 2025-10-28, after the Hampshire location was removed on 2025-03-06.SummaryDifference0.7%

- Check105 days agoChange DetectedSignificant update to operating status and version bumped to v3.2.0; removes reference to v3.1.0.SummaryDifference4%

Stay in the know with updates to Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.